Detalles de la búsqueda
1.
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome.
J Pharmacol Exp Ther
; 373(2): 193-203, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075870
2.
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists.
Bioorg Med Chem Lett
; 21(9): 2641-5, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21295475
3.
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.
Am J Physiol Endocrinol Metab
; 299(6): E1076-86, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20923958
4.
In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
Biochem Biophys Res Commun
; 394(2): 366-71, 2010 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20211605
5.
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity.
Bioorg Med Chem Lett
; 20(22): 6797-801, 2010 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20851601
6.
Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists.
J Med Chem
; 62(10): 4991-5005, 2019 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022340
7.
Additive effect of simultaneous continuous administration of degarelix and TAK-448 on LH suppression in a castrated rat model.
Eur J Pharmacol
; 824: 24-29, 2018 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378196
8.
Biological activity of AC3174, a peptide analog of exendin-4.
Regul Pept
; 141(1-3): 113-9, 2007 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-17292977
9.
Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance.
J Med Chem
; 59(7): 3129-39, 2016 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26986178
10.
Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists.
J Med Chem
; 45(12): 2417-24, 2002 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-12036351
11.
In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.
J Med Chem
; 46(5): 670-3, 2003 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-12593645
12.
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity.
Bioorg Med Chem Lett
; 17(18): 5245-50, 2007 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17632003
13.
Potent and selective, sulfamide-based human beta 3-adrenergic receptor agonists.
Bioorg Med Chem Lett
; 14(12): 3235-40, 2004 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-15149682
14.
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals.
J Biol Chem
; 278(39): 37099-111, 2003 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-12842871
15.
Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics.
Bioorg Med Chem Lett
; 13(3): 379-82, 2003 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12565933
Resultados
1 -
15
de 15
1
Próxima >
>>